Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16541489 | 1.00 | BRD4 (0.41) | BRD4SMN1; SMN2ALDH1A1MEN1KMT2A | |
| SCHEMBL60903 | 0.98 | BRD4 (0.41) | BRD4SMN1; SMN2ALDH1A1MEN1KMT2A | |
| SCHEMBL265557 | 0.93 | SMN1; SMN2 (0.45) | BRD4SMN1; SMN2ALDH1A1MEN1KMT2A | |
| SCHEMBL2289941 | 0.91 | — | — | |
| SCHEMBL21328019 | 0.85 | ALDH1A1 (0.39) | BRD4SMN1; SMN2ALDH1A1MEN1KMT2A | |
| SCHEMBL16471455 | 0.84 | BRD4 (0.40) | BRD4SMN1; SMN2MEN1KMT2APOLB | |
| SCHEMBL1439277 | 0.83 | CYP3A4 (0.40) | SMN1; SMN2ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL16841440 | 0.83 | BRD4 (0.41) | BRD4SMN1; SMN2ALDH1A1MEN1KMT2A | |
| SCHEMBL16751006 | 0.83 | BRD4 (0.41) | BRD4SMN1; SMN2ALDH1A1MEN1KMT2A | |
| SCHEMBL29642954 | 0.83 | FFAR3 (0.37) | SMN1; SMN2ALDH1A1MEN1KMT2AFFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112041316-B | Isoxazole O-linked carbamoyl cyclohexyl acids as LPA antagonists | 百时美施贵宝公司 | 2024-11-22 | — | — | CN | disclosed |
| US-20230221640-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2023-07-13 | — | — | US | disclosed |
| EP-4124616-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS | Alkermes Pharma Ireland Limited (IE) | 2023-02-01 | — | — | EP | disclosed |
| EP-2445502-B2 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS | ALKERMES PHARMA IRELAND LTD (IE) | 2022-09-28 | — | — | EP | disclosed |
| US-11256173-B2 | Treatment liquid for manufacturing semiconductor and pattern forming method | FUJIFILM CORPORATION (JP) | 2022-02-22 | — | — | US | disclosed |
| US-20210103217-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMING METHOD, AND PHOTO MASK | FUJIFILM CORPORATION (JP) | 2021-04-08 | — | — | US | disclosed |
| WO-2019179928-A1 | SUBSTITUTED SUCCINIMIDE-3-CARBOXAMIDES, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2019-09-26 | — | — | WO | disclosed |
| US-20190025702-A1 | TREATMENT LIQUID FOR MANUFACTURING SEMICONDUCTOR AND PATTERN FORMING METHOD | FUJIFILM CORPORATION (JP) | 2019-01-24 | — | — | US | disclosed |
| US-10040787-B2 | Prodrugs of NH-acidic compounds | ALKERMES PHARMA IRELAND LIMITED (IE) | 2018-08-07 | — | — | US | disclosed |
| US-10011569-B2 | Process for synthesizing oxidized lactam compounds | ALKERMES PHARMA IRELAND LIMITED (IE) | 2018-07-03 | — | — | US | disclosed |
| US-4347160-A | Titanium halide catalyst system | STAUFFER CHEMICAL COMPANY (US) | 1982-08-31 | — | — | US | disclosed |
| US-4325836-A | Novel titanium halide containing catalyst | STAUFFER CHEMICAL COMPANY (US) | 1982-04-20 | — | — | US | disclosed |
| EP-0044445-A2 | Titanium halide containing catalyst | STAUFFER CHEMICAL COMPANY (US) | 1982-01-27 | — | — | EP | disclosed |
| US-4312782-A | COORDINATION CATALYST FOR POLYMERIZATION OF ALPHA OLEFINS | STAUFFER CHEMICAL COMPANY (US) | 1982-01-26 | — | — | US | disclosed |
| EP-0043185-A1 | Method for production of titanium halide catalyst component, catalyst system including such component, and polymerization of alpha-olefins using such system | STAUFFER CHEMICAL COMPANY (US) | 1982-01-06 | — | — | EP | disclosed |
| EP-0040711-A1 | Titanium halide catalyst for polymerization | STAUFFER CHEMICAL COMPANY (US) | 1981-12-02 | — | — | EP | disclosed |
| US-4294948-A | Process for preparing olefin polymers or copolymers, and catalyst for use in said process | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1981-10-13 | — | — | US | disclosed |
| US-4232139-A | Process for producing polymers or copolymers of olefins containing at least 3 carbon atoms | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1980-11-04 | — | — | US | disclosed |
| US-4221894-A | MAGNESIUM HALIDE, TITANIUM, ORGANOALUMINUM, ESTER | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1980-09-09 | — | — | US | disclosed |
| US-4143223-A | TITANIUM, HALOGEN, ALUMINUM, ESTER AND AN ALCOHOL | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1979-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10011569-B2 | Process for synthesizing oxidized lactam compounds | COASY, DHPS, OXA1L | BRD4 2924/4885SMN1; SMN2 3665/4885ALDH1A1 113/4885 |
| US-10040787-B2 | Prodrugs of NH-acidic compounds | SI, NAAA, NIT2 | BRD4 2833/4885SMN1; SMN2 606/4885ALDH1A1 1082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.